- Parties: The plaintiff was JAMP Pharma Corporation. The defendant was Xymogen IP, LLC.

- Subject Matter: This action involved JAMP Pharma Corporation alleging that Xymogen IP, LLC infringed its registered trade mark rights. The plaintiff claimed that the defendant’s use of certain marks in Canada created confusion and violated the Trade-marks Act. This case is ongoing.

- Date: The hearing was set on October 3, 2025.

- Venue: This was a federal case before the Federal Court, with proceedings managed in Montréal and Ottawa.

- Amount: No financial award was specified.